- Home
- SUPN vs VIAV Comparison
SUPN vs VIAV Comparison
Compare SUPN & VIAV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SUPN
- VIAV
- Stock Information
- Founded
- SUPN 2005
- VIAV 1923
- Country
- SUPN United States
- VIAV United States
- Employees
- SUPN N/A
- VIAV N/A
- Industry
- SUPN Biotechnology: Pharmaceutical Preparations
- VIAV Semiconductors
- Sector
- SUPN Health Care
- VIAV Technology
- Exchange
- SUPN Nasdaq
- VIAV Nasdaq
- Market Cap
- SUPN 1.9B
- VIAV 2.2B
- IPO Year
- SUPN 2012
- VIAV 1993
- Fundamental
- Price
- SUPN $35.57
- VIAV $9.91
- Analyst Decision
- SUPN Hold
- VIAV Buy
- Analyst Count
- SUPN 1
- VIAV 8
- Target Price
- SUPN $36.00
- VIAV $11.25
- AVG Volume (30 Days)
- SUPN 422.4K
- VIAV 2.0M
- Earning Date
- SUPN 11-04-2024
- VIAV 10-31-2024
- Dividend Yield
- SUPN N/A
- VIAV N/A
- EPS Growth
- SUPN 130.79
- VIAV N/A
- EPS
- SUPN 1.07
- VIAV N/A
- Revenue
- SUPN $651,972,000.00
- VIAV $990,700,000.00
- Revenue This Year
- SUPN $7.82
- VIAV $4.76
- Revenue Next Year
- SUPN N/A
- VIAV $6.97
- P/E Ratio
- SUPN $33.25
- VIAV N/A
- Revenue Growth
- SUPN 6.79
- VIAV N/A
- 52 Week Low
- SUPN $25.53
- VIAV $6.60
- 52 Week High
- SUPN $39.37
- VIAV $11.32
- Technical
- Relative Strength Index (RSI)
- SUPN 53.46
- VIAV 56.81
- Support Level
- SUPN $35.87
- VIAV $9.48
- Resistance Level
- SUPN $39.37
- VIAV $10.72
- Average True Range (ATR)
- SUPN 1.69
- VIAV 0.33
- MACD
- SUPN 0.03
- VIAV -0.00
- Stochastic Oscillator
- SUPN 36.03
- VIAV 52.87
About SUPN Supernus Pharmaceuticals Inc.
Supernus Pharmaceuticals Inc is a specialty pharmaceutical company. The company is engaged in developing and commercializing products for the treatment of central nervous system diseases, including neurological and psychiatric disorders. The Company's diverse neuroscience portfolio includes approved treatments for epilepsy, migraine, attention-deficit hyperactivity disorder (ADHD), hypomobility in Parkinson's Disease (PD), cervical dystonia, chronic sialorrhea, dyskinesia in PD patients receiving levodopa-based therapy, and drug-induced extrapyramidal reactions in adult patients. The company products include Trokendi XR, Oxtellar XR, Qelbree, APOKYN, XADAGO, MYOBLOC, GOCOVRI, and Osmolex ER.
About VIAV Viavi Solutions Inc.
Viavi Solutions Inc. is a global provider of network test, monitoring and assurance solutions to communications service providers, enterprises, network equipment manufacturers, civil government, military and avionics customers. The company also offers high-performance thin-film optical coatings, providing light management solutions to anti-counterfeiting, 3D sensing, electronics, automotive, defense and instrumentation markets. Its operating segments include Network Enablement, Service Enablement, and Optical Security and Performance Products. Geographically, it derives a majority of revenue from the United States.